Oncodiagnostic Laboratory Inc is categorized under Pathological Laboratories in Cleveland, OH and active since 2010.
Oncodiagnostic Laboratory Inc was established in 2010, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Joseph Galang at the company’s single location by writing to 812 Huron Road East # 520, Cleveland, Ohio OH 44115 or by phoning (216) 861-5846. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Oncodiagnostic Laboratory Inc |
Contact Person: | Joseph Galang |
Address: | 812 Huron Road East # 520, Cleveland, Ohio 44115 |
Phone Number: | (216) 861-5846 |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Pathological Laboratories |
SIC Code: | 8071 |
NAICS Code: | 621511 |
Share This Business: |
Oncodiagnostic Laboratory Inc was started in 2010 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Joseph Galang for inquiries that concern Oncodiagnostic Laboratory Inc by calling the company number (216) 861-5846, as your correspondence is most welcome. Additionally, the physical location of the single location of Oncodiagnostic Laboratory Inc can be found at the coordinates 41.498501,-81.686265 as well as the street address 812 Huron Road East # 520 in Cleveland, Ohio 44115.
For its online presence, you may visit Oncodiagnostic Laboratory Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.